Article citationsMore>>

EMA/451665/2023 (2023) European Medicines Agency Appendix 2 to Questions and Answers for Marketing Authorisation Holders/Applicants on the CHMP Opinion for the Article 5(3) of Regulation (EC) No 726/2004 Referral on Nitrosamine Impurities in Human Medicinal Products Carcinogenic Potency Categorisation Approach for Nitrosamines.

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top